Brief: Anavex Life Sciences Announces Peer-Reviewed Publication Of Oral Blarcamesine Phase Iib/Iii Data In The Journal Of Prevention Of Alzheimer’S Disease
15/01/2025 13:06
Jan 15 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES ANNOUNCES PEER-REVIEWED PUBLICATION
OF ORAL
BLARCAMESINE PHASE IIB/III DATA IN THE JOURNAL OF PREVENTION OF
ALZHEIMER’S DISEASE
Source text: ID:nGNX818dhc
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board